Summary mAbs and maternal vaccines targeting RSV have the potential to reduce
paediatric morbidity, however this new era of RSV prevention will require ongoing research …

Respiratory syncytial virus (RSV) is a well-known infant pathogen transmitted mainly by
droplets. It is a leading cause of upper respiratory tract infections in children, usually with a …

Background The COVID-19 pandemic is reported to have affected the epidemiology of
respiratory syncytial virus (RSV), which could have important implications for RSV …

Objectives The purpose of this study was to assess the long-term effectiveness of COVID-19
pandemic prevention measures in saving lives after European governments began to lift …

There is a need in clinical microbiology and public health for assays that enable sensitive
and rapid detection of infectious agents. Next Generation Sequencing (NGS) is increasingly …

Background: RSV often leads to hospitalization, and accurate knowledge of risk factors is
crucial. Methods: We retrospectively analyzed laboratory-confirmed RSV hospitalizations …

Objectives This study aimed to explore how African migrant women go about acquiring clay
for ingestion during pregnancy in London against a backdrop of restrictions and warnings by …

Respiratory syncytial virus (RSV) is the most common pathogen causing respiratory tract
infections in infants, affecting over 90% of children within the first two years of life. It may …

Abstract Background In China, respiratory syncytial virus (RSV) infections traditionally occur
during the spring and winter seasons. However, a shift in the seasonal trend was noted in …

Background Respiratory syncytial virus (RSV), a single-stranded RNA virus, is a leading
cause of hospitalization in infants, especially≤ 2 months of life. In the light new …